ATE458038T1 - Kulturemedium für menschlichen blastozyste - Google Patents

Kulturemedium für menschlichen blastozyste

Info

Publication number
ATE458038T1
ATE458038T1 AT04808656T AT04808656T ATE458038T1 AT E458038 T1 ATE458038 T1 AT E458038T1 AT 04808656 T AT04808656 T AT 04808656T AT 04808656 T AT04808656 T AT 04808656T AT E458038 T1 ATE458038 T1 AT E458038T1
Authority
AT
Austria
Prior art keywords
culture media
human blastocyst
human
nucleus
oocyte
Prior art date
Application number
AT04808656T
Other languages
English (en)
Inventor
Sung-Il Roh
Woo-Suk Hwang
Byeong-Chun Lee
Sung-Keun Kang
Young-June Ryu
Eu-Gene Lee
Soon-Woong Kim
Dae-Kee Kwon
Hee-Sun Kwon
Ja-Min Koo
Eul-Soon Park
Youn-Young Hwang
Shin-Yong Moon
Sun-Kyung Oh
Cu-Rie Ahn
Hyun-Soo Yoon
Jong-Hyuk Park
Sun-Jong Kim
Yang-Kyu Choi
Original Assignee
Bion Co Ltd H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34737817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE458038(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bion Co Ltd H filed Critical Bion Co Ltd H
Application granted granted Critical
Publication of ATE458038T1 publication Critical patent/ATE458038T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8776—Primate embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT04808656T 2003-12-30 2004-12-30 Kulturemedium für menschlichen blastozyste ATE458038T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR0302899 2003-12-30
PCT/KR2004/003528 WO2005063972A1 (en) 2003-12-30 2004-12-30 Embryonic stem cell line and method for preparing the same

Publications (1)

Publication Number Publication Date
ATE458038T1 true ATE458038T1 (de) 2010-03-15

Family

ID=34737817

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04808656T ATE458038T1 (de) 2003-12-30 2004-12-30 Kulturemedium für menschlichen blastozyste

Country Status (12)

Country Link
US (4) US20070243610A1 (de)
EP (1) EP1711599B1 (de)
JP (1) JP2007516720A (de)
KR (2) KR20160139045A (de)
CN (1) CN1922307A (de)
AT (1) ATE458038T1 (de)
AU (1) AU2004309300B8 (de)
BR (1) BRPI0418310A (de)
CA (1) CA2551266C (de)
DE (1) DE602004025623D1 (de)
RU (1) RU2006127446A (de)
WO (1) WO2005063972A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100817020B1 (ko) * 2006-10-30 2008-03-27 건국대학교 산학협력단 셀레늄을 유효성분으로 하는 배아 발생 개선용 조성물 및그 방법
WO2012068170A2 (en) * 2010-11-15 2012-05-24 Jau-Nan Lee Generation of neural stem cells from human trophoblast stem cells
EP2956542A4 (de) 2013-02-15 2016-09-14 Sungkwang Medical Foundation Herstellung parthenogenetischer stammzellen und patientenspezifischer menschlicher embryonischer stammzellen unter verwendung eines somazellkerntransfers
EP2997131A4 (de) * 2013-05-13 2016-10-26 Univ Oregon Health & Science Durch somatischen zellkerntransfer hergestellte menschliche pluripotente stammzellen
WO2015081182A1 (en) 2013-11-27 2015-06-04 The Curators Of The University Of Missouri Artificial oocyte activation
WO2017014513A1 (ko) * 2015-07-17 2017-01-26 의료법인 성광의료재단 Nt세포의 보관방법 및 뱅킹 시스템
US12091679B2 (en) 2015-07-17 2024-09-17 Sungkwang Medical Foundation Storage method and banking system of NT cell
US11535824B2 (en) 2015-10-29 2022-12-27 Sung Kwang Medical Foundation Nuclear transfer
CN106399229A (zh) * 2016-10-25 2017-02-15 浙江译美生物科技有限公司 一种诱导剂及采用该诱导剂制备表皮干细胞的方法
CN106754654A (zh) * 2016-12-02 2017-05-31 内蒙古大学 以干细胞为基础的哺乳动物人工胚胎构建‑动物克隆繁育的方法及其模型
CN106834207A (zh) * 2016-12-14 2017-06-13 中国水产科学研究院珠江水产研究所 一种中华鳖卵巢细胞分离及体外培养方法
CN113151158A (zh) * 2021-05-19 2021-07-23 杭州憶盛医疗科技有限公司 一种组织干细胞分离和功能评价系统
WO2023008918A1 (ko) * 2021-07-28 2023-02-02 의료법인 성광의료재단 B2m 유전자의 발현이 저해된 유전적으로 조작된 줄기세포 및 이의 이용방법
CN115927169B (zh) * 2022-10-11 2023-08-11 再造再生医学科技(杭州)有限公司 用于扩增cd34+造血干细胞的培养液和体外扩增cd34+造血干细胞的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0230430A4 (de) 1985-06-12 1989-03-09 Luminis Pty Ltd Kulturmedium für in-vitro-befruchtung und embryo-übertragung.
CN1304444A (zh) 1999-06-30 2001-07-18 黄禹锡 一种通过用种间核转移技术生产人类克隆胚胎的方法
JP2001017160A (ja) * 1999-07-07 2001-01-23 Fuso Pharmaceutical Industries Ltd 体外受精用培地組成物
WO2001088104A2 (en) 2000-05-17 2001-11-22 Geron Corporation Neural progenitor cell populations
WO2002086073A2 (en) * 2001-04-20 2002-10-31 Memorial Sloan-Kettering Cancer Center Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use

Also Published As

Publication number Publication date
US9476064B2 (en) 2016-10-25
AU2004309300B8 (en) 2009-03-26
CA2551266A1 (en) 2005-07-14
US20120083032A1 (en) 2012-04-05
KR101680269B1 (ko) 2016-11-29
EP1711599B1 (de) 2010-02-17
EP1711599A1 (de) 2006-10-18
JP2007516720A (ja) 2007-06-28
KR20160139045A (ko) 2016-12-06
CA2551266C (en) 2011-07-26
US20110065192A1 (en) 2011-03-17
KR20060105041A (ko) 2006-10-09
AU2004309300B2 (en) 2008-06-12
AU2004309300A1 (en) 2005-07-14
US20140154800A1 (en) 2014-06-05
CN1922307A (zh) 2007-02-28
BRPI0418310A (pt) 2007-05-02
EP1711599A4 (de) 2008-04-16
US8647872B2 (en) 2014-02-11
DE602004025623D1 (de) 2010-04-01
US20070243610A1 (en) 2007-10-18
RU2006127446A (ru) 2008-02-10
WO2005063972A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
ATE458038T1 (de) Kulturemedium für menschlichen blastozyste
Ramos-Ibeas et al. Pluripotency and X chromosome dynamics revealed in pig pre-gastrulating embryos by single cell analysis
Duranthon et al. Preimplantation embryo programming: transcription, epigenetics, and culture environment
DK2218776T3 (da) Dyreproteinfrit celledyrkningsmedie til dyrkning af celler
EP4223769A3 (de) Nuklearer neuprogrammierungsfaktor
SE0850111L (sv) Förfarande för differentiering av stamceller till celler av den endodermala och pankreatiska utvecklingslinjen
WO2007047979A3 (en) Parthenogenic activation of human oocytes for the production of human embryonic stem cells
WO2006070370A3 (en) Stem cells culture systems
WO2008036447A3 (en) Pluripotent stem cell culture
BRPI0710949A2 (pt) Método para indução de diferenciação de células tronco pluripotentes em cardiomiócitos
WO2008103462A3 (en) Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells
DK2326706T3 (da) Opdræts- og reproduktionsanlæg til lysintensive mikroorganismer (F.eks. alger)
Oikawa et al. Understanding the X chromosome inactivation cycle in mice: a comprehensive view provided by nuclear transfer
DE602005026548D1 (de) Serumfreies kulturmedium für säugerzellen
Shuai et al. Durable pluripotency and haploidy in epiblast stem cells derived from haploid embryonic stem cells in vitro
Yang et al. The maternal effect genes UTX and JMJD3 play contrasting roles in Mus musculus preimplantation embryo development
IL177493A (en) Use of a serum-free cell culture medium for the production of il-18bp
NO20074027L (no) DNA markorer for oket melkeproduksjon i storfe
Wennekamp et al. Stochastic processes in the development of pluripotency in vivo
EP2145953A4 (de) Zellfreies proteinsynthesesystem mit ursprung in kultivierten säugerzellen
DE602004006508D1 (de) Rührsystem für Zellkultur
Park et al. Establishment, characterization, and validation of novel porcine embryonic fibroblasts as a potential source for genetic modification
SE0602250L (sv) Användning av poröst membran för understödjande av utveckling av somatiska barrträdsembryon
ATE508183T1 (de) Sekretierte proteine für zelldifferenzierungsmarker
Wen et al. Tetraploid embryonic stem cells can contribute to the development of chimeric fetuses and chimeric extraembryonic tissues

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties